One of Deepest Clinical Pipelines on ASX - 3 clinical trials: 2...

  1. 16,246 Posts.
    lightbulb Created with Sketch. 742
    One of Deepest Clinical Pipelines on ASX - 3 clinical trials:
    2 underway and 1 on track to initiate 1H 2016, all under IND Two Clinical Stage Oncology Drugs 2 drug candidates targeting key cancer pathways » Akt (PTX-200) and Ras (PTX-100)

    Distinguished Scientific Provenance Compelling science from leading US institutions – Yale University & Moffitt Cancer Center

    Significant investment already made Over $20 M invested to date » Technologies have been awarded multiple prestigious US government grants

    Proven Leadership & Management Experienced and proven drug development team on board to aggressively drive product development

    Rich Upcoming News Flow Multiple milestone announcements and valuation inflection points across all clinical programs over next 12 to 18 months

    Robust IP Patents granted in major jurisdictions extending to 2030
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.